Skip to main content

Table 2 Clinicopathological characteristics and toxicity profile of DPYD mutation carriers

From: Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients

 

Patient #1

Patient #2

Patient #3

Age

35

64

68

Gender

female

male

female

Tumor

   

   Location

Colorectal

Colorectal

Esophageal

   Type

Adenocarcinoma

Adenocarcinoma

Squamous cell carcinoma

   Stage

IV

IIIB

IV

Treatment regimen

   

Toxicity profile

   

   Mucositis

G3

G4

G4

   Anemia

G4

G0

G0

   Neutropenia

G4

G4

G0

   Thrombocytopenia

G4

G0

G0

DPYD mutation type

1845 G > T

IVS14+1G > A

IVS14+1G > A